Center for Scientific Review; Notice of Closed Meetings, 56652-56653 [E9-26288]
Download as PDF
<![CDATA[
56652
Federal Register / Vol. 74, No. 210 / Monday, November 2, 2009 / Notices
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
December 1, 2009.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact AnnMarie
Williams, 301–796–5966 or
annmarie.williams@fda.hhs.gov by
December 4, 2009.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: October 27, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–26260 Filed 10–30–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2009–N–0664]
Pediatric Advisory Committee;
Amendment of Notice
AGENCY:
Food and Drug Administration,
HHS.
srobinson on DSKHWCL6B1PROD with NOTICES
ACTION:
Notice.
The Food and Drug Administration
(FDA) is announcing an amendment to
the notice of meeting of the Pediatric
Advisory Committee. This meeting was
announced in the Federal Register of
October 6, 2009 (74 FR 51289). The
amendment is being made to reflect a
change in the Agenda portion of the
document. There are no other changes.
FOR FURTHER INFORMATION CONTACT:
Doreen Kezer, Office of Medical and
Scientific Programs, Office of the
Commissioner, Food and Drug
VerDate Nov<24>2008
17:03 Oct 30, 2009
Jkt 220001
Administration, 5600 Fishers Lane (HF–
33), rm. 14–65, Rockville, MD 20857,
301–827–1249, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area), code
8732310001. Please call the Information
Line for up-to-date information on this
meeting.
In the
Federal Register of October 6, 2009,
FDA announced that a meeting of the
Pediatric Advisory Committee would be
held on December 8, 2009. On page
51290, in the first column, the Agenda
portion of the document is changed to
read as follows:
Agenda: On December 8, 2009, the
Pediatric Advisory Committee will meet
to discuss pediatric-focused safety
reviews, as mandated by the Best
Pharmaceuticals for Children Act and
the Pediatric Research Equity Act, for
Abilify (aripiprazole), Argatroban
(argatroban), Orencia (abatacept),
Humira (adalimumab), Cancidas
(caspofungin acetate), Evicel—fibrin
sealant (human), Artiss—fibrin sealant
(human), Voluven—6% hydroxyethyl
starch 130/0.4 in 0.9% sodium chloride
injection, Reyataz (atazanavir sulfate),
Kaletra (lopinavir/ ritonavir), Aptivus
(tipranavir), Zetia (ezetimibe), Vytorin
(ezetimibe/simvastatin), Ventolin HFA
(albuterol sulfate). An update to address
some of the committee’s questions from
the Pediatric Advisory Committee
meeting of November 18, 2008, on
atypical antipsychotic drugs will be
provided. In addition to Abilify
(aripiprazole), Risperidal (risperidone),
Zyprexa (olanzapine), Geodon
(ziprasidone), and Seroquel (quetiapine)
will be included. Two products
(Zemuron (rocuronium bromide) and
Cardiolite (technetium Tc99m
sestamibi) previously planned for
presentation at this meeting are
rescheduled for a later date.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
SUPPLEMENTARY INFORMATION:
Dated: October 27, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–26262 Filed 10–30–09; 8:45 am]
BILLING CODE 4160–01–S
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AIDS
Predoctoral and Postdoctoral Fellowship.
Date: December 2–3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Hilary D. Sigmon, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, (301) 594–
6377, sigmonh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Pharmacogenomics.
Date: December 3–4, 2009.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Michael K. Schmidt, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2214,
MSC 7890, Bethesda, MD 20892, (301) 435–
1147, mschmidt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics in Biological Sciences.
Date: December 3–4, 2009.
Time: 11 a.m. to 10 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Donald L. Schneider, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5160,
MSC 7842, Bethesda, MD 20892, (301) 435–
1727, schneidd@csr.nih.gov.
E:\FR\FM\02NON1.SGM
02NON1
srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 74, No. 210 / Monday, November 2, 2009 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
09–007: ARRA AREA Grants Panel 10.
Date: December 4, 2009.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Maqsood A. Wani, DVM,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2114,
MSC 7814, Bethesda, MD 20892, 301–435–
2270, wanimaqs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Native
American Research Centers for Health.
Date: December 7–8, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Najma Begum, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2186,
MSC 7818, Bethesda, MD 20892, 301–435–
1243, begumn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; P41 Center.
Date: December 8–10, 2009.
Time: 5 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, Los AngelesWestwood, 10740 Wilshire Blvd., Los
Angeles, CA 90024449.
Contact Person: Malgorzata Klosek, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188,
MSC 7849, Bethesda, MD 20892, 301–435–
2211, klosekm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
09–007: ARRA AREA Grants Panel 03.
Date: December 9, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street,
NW., Washington, DC 20036.
Contact Person: Vonda K. Smith, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4148,
MSC 7806, Bethesda, MD 20892, 301–435–
1789, smithvo@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurological Disorders, Bioengineering, and
Neurogenetics.
Date: December 9, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Vilen A. Movsesyan, PhD,
Scientific Review Officer, Center for
VerDate Nov<24>2008
17:03 Oct 30, 2009
Jkt 220001
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M,
MSC 7806, Bethesda, MD 20892, 301–402–
7278, movsesyanv@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Research
Resource in Cell Biology.
Date: December 10–11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The St. Regis Washington DC, 923
16th Street, NW., Washington, DC 20006.
Contact Person: David Balasundaram, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189,
MSC 7840, Bethesda, MD 20892, 301–435–
1022, balasundaramd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
07–009: ARRA AREA Grants Panel 02.
Date: December 10, 2009.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Noni Byrnes, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5130,
MSC 7840, Bethesda, MD 20892, 301–435–
1023, byrnesn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RAID:
Roadmap Initiative 2010/01B.
Date: December 16–18, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Steven J. Zullo, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5146,
MSC 7849, Bethesda, MD 20892, 301–435–
2810, zullost@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts in Biological Chemistry and
Macromolecular Biophysics.
Date: December 17–18, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Donald L. Schneider, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5160,
MSC 7842, Bethesda, MD 20892, 301–435–
1727, schneidd@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
56653
Dated: October 27, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–26288 Filed 10–30–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Exploratory Behaviors HIV/AIDS.
Date: November 10, 2009.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call)
Contact Person: Enid Light, PhD, Scientific
Review Officer, Division of Extramural
Activities, National Institute of Mental
Health, NIH, Neuroscience Center, 6001
Executive Boulevard, Room 6132, MSC 9608,
Bethesda, MD 20852–9608, 301–443–0322,
elight@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: October 26, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–26287 Filed 10–30–09; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\02NON1.SGM
02NON1
]]>Agencies
[Federal Register Volume 74, Number 210 (Monday, November 2, 2009)]
[Notices]
[Pages 56652-56653]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-26288]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AIDS Predoctoral and Postdoctoral Fellowship.
Date: December 2-3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Hilary D. Sigmon, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD
20892, (301) 594-6377, sigmonh@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Pharmacogenomics.
Date: December 3-4, 2009.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Michael K. Schmidt, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2214, MSC 7890, Bethesda, MD
20892, (301) 435-1147, mschmidt@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Special Topics in Biological Sciences.
Date: December 3-4, 2009.
Time: 11 a.m. to 10 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Donald L. Schneider, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5160, MSC 7842, Bethesda, MD
20892, (301) 435-1727, schneidd@csr.nih.gov.
[[Page 56653]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD-09-007: ARRA AREA Grants Panel 10.
Date: December 4, 2009.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Maqsood A. Wani, DVM, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2114, MSC 7814, Bethesda, MD
20892, 301-435-2270, wanimaqs@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Native American Research Centers for Health.
Date: December 7-8, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Najma Begum, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2186, MSC 7818, Bethesda, MD 20892, 301-435-
1243, begumn@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; P41 Center.
Date: December 8-10, 2009.
Time: 5 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Palomar, Los Angeles-Westwood, 10740 Wilshire
Blvd., Los Angeles, CA 90024449.
Contact Person: Malgorzata Klosek, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188, MSC 7849, Bethesda, MD
20892, 301-435-2211, klosekm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD-09-007: ARRA AREA Grants Panel 03.
Date: December 9, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC
20036.
Contact Person: Vonda K. Smith, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4148, MSC 7806, Bethesda, MD 20892, 301-435-
1789, smithvo@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neurological Disorders, Bioengineering, and Neurogenetics.
Date: December 9, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Vilen A. Movsesyan, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M, MSC 7806, Bethesda, MD
20892, 301-402-7278, movsesyanv@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Research Resource in Cell Biology.
Date: December 10-11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The St. Regis Washington DC, 923 16th Street, NW.,
Washington, DC 20006.
Contact Person: David Balasundaram, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD
20892, 301-435-1022, balasundaramd@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD-07-009: ARRA AREA Grants Panel 02.
Date: December 10, 2009.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz Carlton Hotel, 1150 22nd Street, NW., Washington, DC
20037.
Contact Person: Noni Byrnes, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5130, MSC 7840, Bethesda, MD 20892, 301-435-
1023, byrnesn@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RAID: Roadmap Initiative 2010/01B.
Date: December 16-18, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Steven J. Zullo, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5146, MSC 7849, Bethesda, MD 20892, 301-435-
2810, zullost@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts in Biological Chemistry and Macromolecular
Biophysics.
Date: December 17-18, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Donald L. Schneider, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5160, MSC 7842, Bethesda, MD
20892, 301-435-1727, schneidd@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 27, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-26288 Filed 10-30-09; 8:45 am]
BILLING CODE 4140-01-P
